Advertisements



Agile Therapeutics announces FDA approval of Twirla transdermal system

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 14th, 2020

Agile Therapeutics announces FDA extension of Twirla NDA review period

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 14th, 2019

Agile Therapeutics announces favorable outcome of FDA meeting for Twirla

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 30th, 2019

Agile Therapeutics announces FDA advisory committee meeting for Twirla IND

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 24th, 2019

Agile Therapeutics announces FDA acceptance of NDA resubmission of Twirla

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 22nd, 2019

Agile Therapeutics announces Twirla comparative study meets primary endpoint

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 11th, 2019

Why This Analyst Sees New Contraceptive FDA Approval Doubling Agile Therapeutics Stock

Agile Therapeutics shares took a dip on Tuesday after the company announced a key FDA approval for its new weekly contraceptive patch. Yet, one analyst sees great long-term potential, targeting the........»»

Category: blogSource: 247wallstFeb 18th, 2020

Agile Finalizes $35M Term Loan Facility As Twirla PDUFA Date Looms

Agile Therapeutics Inc (NASDAQ: AGRX) shares are advancing Tuesday after the company announced clinching of a term loan facility. read more.....»»

Category: blogSource: benzingaFeb 11th, 2020

Axonics announces FDA approval of second-generation Programmer for r-SNM System

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 21st, 2020

HLS Therapeutics announces Health Canada approval for Vascepa for CV risk

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 31st, 2019

Profound Medical announces Health Canada approval of TULSA-PRO system

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 25th, 2019

Myriad Genetics announces regulatory approval of BRACAnalysis system in Japan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 21st, 2019

William Blair still thinks Agile likely to get approval for Twirla despite delay

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 15th, 2019

Axonics announces FDA approval of Axonics r-SNM System

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 14th, 2019

Agile Therapeutics: Stock Hits 52-Week Low And A Near 52-Week High Around Twirla"s AdCom

Agile Therapeutics: Stock Hits 52-Week Low And A Near 52-Week High Around Twirla"s AdCom.....»»

Category: topSource: seekingalphaNov 6th, 2019

Agile Therapeutics" stock rockets nearly 4-fold after contraceptive patch Twirla gets favorable FDA committee nod

Shares of Agile Therapeutic.....»»

Category: topSource: marketwatchOct 31st, 2019

Medtronic announces Shonin approval, launch of Valiant Navion graft system

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 31st, 2019

Agile Therapeutics says continuing to prepare for FDA meeting on Twirla

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 28th, 2019

Melinta Therapeutics announces FDA approval for Baxdela

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 24th, 2019

United Therapeutics announces FDA approval of sNDA for Orenitram E-R Tablets

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 21st, 2019

Medtronic announces FDA approval of Evolut PRO+ TAVR System

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 23rd, 2019